Funds And Strategies
  • Business
  • Stocks
  • World News
  • Investing
  • Business
  • Stocks
  • World News
  • Investing

Funds And Strategies

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

previous post
5 Biggest Blockchain ETFs in 2025
next post
Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines

Related Posts

Justin Huhn: Uranium Game On — Supply “Mirage,”...

June 6, 2025

Syntheia Announces Private Placement

May 30, 2025

Peter Goodburn: Silver “Very Undervalued” vs. Gold —...

May 22, 2025

Trading Halt

April 30, 2025

Coinbase Backs QCAD Stablecoin to Power Canadian Crypto...

May 17, 2025

Spodumene Pegmatite Discovered at Agboville and Rubino

May 22, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (89)
    • Investing (318)
    • Stocks (107)
    • World News (391)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 fundsandstrategies.com | All Rights Reserved